Zydus Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences Limited and 36 members of the Zydus promoter group submitted declarations to BSE and NSE under SEBI Regulation 31(4) of the Takeover Regulations, 2011. The filings confirm that none of the promoters or persons acting in concert have created any encumbrance (such as pledging shares as collateral) on their equity shares of Zydus Wellness Limited during the Financial Year ended March 31, 2026. The declarations cover individuals including Pankaj R. Patel, Sharvil P. Patel, and family members, as well as entities like Zydus Family Trust, Taraben Patel Family Will Trust, and various Zydus group companies. Some entities specifically stated they do not hold any equity shares of Zydus Wellness Limited.
This is a routine compliance filing confirming the promoter group has not pledged their shares in Zydus Wellness Limited. The absence of encumbrances is a positive signal for shareholders as it indicates promoters have not hypothecated their holdings, reducing risk of potential share supply pressure. No direct impact on stock price expected from this filing.